BLFS vs FEMY โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BLFS Captures Institutional Edge (3โ1 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BioLife Solutions Inc. (BLFS) driven by superior Valuation, Growth & Margin, Options & Structure while FEMY counters with relative strength in Momentum & Technical. Fundamentally, BLFS trades at 117.0x Forward P/E with 6.0% operating margin (+21.5% YoY revenue) versus FEMY at N/M Forward P/E and -763.9% operating margin (-18.9% YoY). In options structure, BLFS sits in BREAKOUT (6th %ile IV; Dealer Gamma Walls on Pro) against FEMY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | BLFS Revenue | FEMY Revenue | BLFS Op. Margin | FEMY Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $20M | N/A | 18.5% | N/A | BLFS |
| FY2019 | $30M | N/A | -0.8% | N/A | BLFS |
| FY2020 | $50M | $0M | -13.0% | -668.0% | BLFS |
| FY2021 | $120M | $0M | -29.5% | -706.7% | BLFS |
| FY2022 | $80M | $0M | -7.8% | -961.7% | BLFS |
| FY2023 | $70M | $0M | -25.3% | -1353.4% | BLFS |
| FY2024 | $70M | $0M | -6.0% | -1091.8% | BLFS |
| FY2025 | $100M | $0M | -17.3% | -767.0% | BLFS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BLFS | FEMY | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.8B | $11.9M | Larger Scale | BLFS |
| Trailing P/E Ratio Valuation | 37.3x | N/M | Lower Multiple | BLFS |
| Forward P/E Ratio Valuation | 117.0x | N/M | Lower Multiple | BLFS |
| Revenue Growth (YoY) Growth | +21.5% | -18.9% | Higher Growth | BLFS |
| Operating Margin (TTM) Profitability | 6.0% | -763.9% | Higher Margin | BLFS |
| Net Profit Margin Profitability | 54.4% | 0.0% | Higher Margin | BLFS |
| Return on Equity (ROE) Capital Efficiency | 12.8% | -425.0% | Higher ROE | BLFS |
| 52-Week Range Position Momentum | 95% ($18โ$40) | 17% ($0โ$6) | Stronger Trend | BLFS |
| Beta / 30D Volatility Risk Regime | 1.05ฮฒ ยท 31% Vol | 4.01ฮฒ ยท 72% Vol | Lower Realized Risk | BLFS |
| Unified Institutional Score Composite Signal | 46.0 / 100 (HOLD) | 52.6 / 100 (HOLD) | Higher Composite | FEMY |